New possibilities of treatment of low back pain

Kamchatnov P.R.; Chugunov A.V.; Khanmurzaeva S.B.

doi:https://doi.org/10.17116/jnevro2017117121162-167

Close metadata

Recommended articles:

Combined treatment of patients with acute muscular tonic syndrome with dorsopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):70-77

Stress and sleep: Neurobiological aspects and modern options of insomnia therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):14-21

Cognitive impairment in patients with multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73

Early diagnosis and effective therapy of diabetic polyneuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):62-68

Characteristics, treatment features and in-hospital mortality of patients with myocardial infarction over 75 years old in Russia according to the REGION-IM registry. Russian Cardiology Bulletin. 2025;(1):22-38

Pharmacological treatment and prevention of ischemia-reperfusion syndrome in percutaneous coronary intervention. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):191-200

Influence of griseofulvin on intestinal microbiota in the treatment of microsporia in rural children. Russian Journal of Clinical Dermatology and Venereology. 2025;(2):185-190

Aseptic osteitis of the tibia after intraarticular injection of hyaluronic acid in a patient with knee osteoarthritis. Russian Journal of Archive of Pathology. 2025;(2):69-72

Review and resolution of the Council of Experts on the topic «The role of the combination of undenatured type II collagen UC-II, vitamin C, and trace elements in recovering and maintaining the function of the musculoskeletal system, and preservation of health of the joints». Russian Journal of Preventive Medicine. 2025;(4):102-110

Postoperative peritonitis: epidemiology, diagnosis, surgical treatment and prognosis. Pirogov Russian Journal of Surgery. 2025;(6):104-111

Abstract:

Low back pain (LBP) is a syndrome caused by degenerative spine diseases and a common reason for referral for medical care. LBP is mostly often caused by osteoarthritis (OA) that needs long-term treatment with nonsteroidal anti-inflammatory drugs. The treatment is associated with a risk of side-effects. The authors consider the possibility of using slow-acting drugs for symptomatic treatment of OA (SYSADOA) in patients with LBP and present the data on anti-inflammatory effects of chondroitin sulfate on the chondral tissue in OA. The results of the studies on the use of SYSADOA in LBP are analyzed.

Keywords:

low back pain

osteoarthritis

SYSADOA

chondroitin sulfate

treatment

Authors:

Kamchatnov P.R.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta im. N.I. Pirogova, Moskva

SPIN RSCI: 9240-6754
Scopus AuthorID: 6602401209
ORCID: 0000-0001-6747-3476

Chugunov A.V.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta im. N.I. Pirogova, Moskva

Scopus AuthorID: 7004437778

Khanmurzaeva S.B.

Dagestan State Medical University, Makhachkala, Dagestan, Russia

Close metadata

References:

McIntosh G, Hall H. Low back pain (acute). BMJ Clin Evid. 2011;1102.
Le TK, Montejano LB, Cao Z, Zhao Y, Ang D. Health care costs in US patients with and without a diagnosis of osteoarthritis. J Pain Res. 2012;5:23-30. https://doi.org/10.2147/JPR.S27275.
Schneider S, Schmitt H, Zoller S, Schiltenwolf M. Workplace stress, lifestyle and social factors as correlates of back pain: a representative study of the German working population. Int Arch Occup Environ Health. 2005;78(4):253-269. https://doi.org/10.1007/s00420-004-0576-4
Borenstein D. Does osteoarthritis of the lumbar spine cause chronic low back pain? Curr Pain Headache Rep. 2004;8:512-517.
Martel-Pelletier J, Lajeunesse D, Pelletier JP. Etiopathogenesis of osteoarthritis. In: Koopman WJ, Moreland LW, editor. Arthritis and Allied Conditions: A Textbook of Rheumatology. Baltimore: Lippincott, Williams Wilkins; 2005.
Lajeunesse D, Massicotte F, Pelletier JP, Martel-Pelletier J. Subchondral bone sclerosis in osteoarthritis: not just an innocent bystander. Mod Rheumatol. 2003;13(1):7-14. https://doi.org/10.3109/s101650300001.
Poulet B, Staines K. New developments in osteoarthritis and cartilage biology. Currt Opin in Pharmacology. 2016;28:8-13. https://doi.org/10.1016/j.coph.2016.02.009
Ashraf S, Walsh DA. Angiogenesis in osteoarthritis. Curr Opin Rheumatol. 2008;20(5):573-580. https://doi.org/10.1097/BOR.0b013e3283103d12
Nikiforov AS, Avakyan GN. Nevrologicheskie oslozhneniya osteohondroza pozvonochnika. М.: Medpraktika; 2011. (In Russ.)
Hong J, Ball P. Resolution of Lumbar Disk Herniation without Surgery. N Engl J Med. 2016;374(16):1654. https://doi.org/10.1056/NEJMicm1511194.
Sharma H, Gupta R, Olivero W. fMRI in patients with lumbar disc disease: a paradigm to study patients over time. J of Pain Res. 2011;4:401-405. https://doi.org/10.2147/JPR.S24393
Gusev EI, Nikiforov AS, Kamchatnov PR. Nevrologicheskie simptomy, sindromy i bolezni. 2-e izd. M.: Gehotar-Medika; 2014. (In Russ.)
Qaseem A, Wilt TJ, McLean RM, Forciea MA; Clinical Guidelines Committee of the American College of Physicians. Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2017;166(7):514-530. https://doi.org/10.7326/M16-2367
Hagen K, Jamtvedt G, Hilde G, Winnem M. Bed rest bad for back pain, ineffective for sciatica. The updated Cochrane Review of bed rest for low back pain and sciatica. Spine. 2005;30:542-546.
van Middelkoop M, Rubinstein S, Verhagen A, Ostelo R, Koes B, van Tulder M. Exercise therapy for chronic nonspecific low-back pain. Best Pract Res Clin Rheumatol. 2010;24(2):193-204. https://doi.org/10.1016/j.berh.2010.01.002.
Helin-Salmivaara A, Saarelainen S, Grönroos JM, Vesalainen R, Klaukka T, Huupponen R. Risk of upper gastrointestinal events with the use of various NSAIDs: a case-control study in a general population. Scand J Gastroenterol. 2007;42(8):923-932. https://doi.org/10.1080/00365520701192326
Becker MC, Wang TH, Wisniewski L, Wolski K, Libby P, Lüscher TF, Borer JS, Mascette AM, Husni ME, Solomon DH, Graham DY, Yeomans ND, Krum H, Ruschitzka F, Lincoff AM, Nissen SE; PRECISION Investigators. Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. Am Heart J. 2009;157(4):606-612. https://doi.org/10.1016/j.ahj.2008.12.014
Lippielo L, Woodword J, Karpman D. Beneficial effect of cartilage structure modyifing agents tested in chondrocyte and rabbit instability model osteoartrosis. Arthr Rheum. 1999;42:256-261.
Monfort J, Pelletier JP, Garcia-Giralt N, Martel-Pelletier J. Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues. Ann Rheum Dis. 2008;67(6):735-740. https://doi.org/10.1136/ard.2006.068882
Dougados M. Symptomatic slow-acting drugs for osteoarthritis: what are the facts? Joint Bone Spine. 2006;73(6):606-609. https://doi.org/10.1016/j.jbspin.2006.09.008
Souich P, García A, Vergés J, Montell E. Immunomodulatory and anti-inflammatory effects of chondroitin sulphate. J Cell Mol Med. 2009;13(8a): 1451-1463. https://doi.org/10.1111/j.1582-4934.2009.00826.x
Jomphe C, Gabriac M, Hale TM, Héroux L, Trudeau LE, Deblois D, Montell E, Vergés J, du Souich P. Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-kappaB in interleukin-1beta-stimulated chondrocytes. Basic Clin Pharmacol Toxicol. 2008;102(1):59-65. https://doi.org/10.1111/j.1742-7843.2007.00158.x
Iovu M, Dumais G, du Souich P. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage. 2008;16(3):14-18. https://doi.org/10.1016/j.joca.2008.06.008
Tat SK, Pelletier JP, Vergés J, Lajeunesse D, Montell E, Fahmi H, Lavigne M, Martel-Pelletier J. Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study. Arthritis Res Ther. 2007;9(6):117. https://doi.org/10.1186/ar2325
Martel-Pelletier J, Farran A, Montell E, Vergés J, Pelletier JP. Discrepancies in composition and biological effects of different formulations of chondroitin sulfate. Molecules. 2015;20(3):4277-4289. https://doi.org/10.3390/molecules20034277
Michel BA1, Stucki G, Frey D, De Vathaire F, Vignon E, Bruehlmann P, Uebelhart D. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis Rheum. 2005;52(3):779-786. https://doi.org/10.1002/art.20867
Kahan A, Uebelhart D, De Vathaire F, Delmas PD, Reginster JY.Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2009;60(2):524-533. https://doi.org/10.1002/art.24255.
Uebelhart D, Malaise M, Marcolongo R, de Vathaire F, Piperno M, Mailleux E, Fioravanti A, Matoso L, Vignon E. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthritis Cartilage. 2004;12(4):269-276. https://doi.org/10.1016/j.joca.2004.01.004
Verbruggen G, Goemaere S, Veys EM. Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs. Clin Rheumatol. 2002;21(3):231-243.
Fransen M, Agaliotis M, Nairn L, Votrubec M, Bridgett L, Su S, Jan S, March L, Edmonds J, Norton R, Woodward M, Day R. LEGS study collaborative group. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebocontrolled clinical trial evaluating single and combination regimens. Ann Rheum Dis. 2015;74:851-858. https://doi.org/10.1136/annrheumdis-2013-203954
Clegg DO, Reda DJ, Harris CL, Klein MA, O’Dell JR, Hooper MM, Bradley JD, Bingham CO 3rd, Weisman MH, Jackson CG, Lane NE, Cush JJ, Moreland LW, Schumacher HR Jr, Oddis CV, Wolfe F, Molitor JA, Yocum DE, Schnitzer TJ, Furst DE, Sawitzke AD, Shi H, Brandt KD, Moskowitz RW, Williams HJ. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354: 795-808. https://doi.org/10.1056/NEJMoa052771
Singh JA, Noorbaloochi S, MacDonald R, Maxwell LJ. Chondroitin for osteoarthritis. Cochrane Database Syst Rev. 2015;1:005614. https://doi.org/10.1002/14651858.CD005614.pub2
Reginster JY, Dudler J, Blicharski T, Pavelka K. Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT). Ann Rheum Dis. 2017;76:1537-1543. https://doi.org/10.1136/annrheumdis-2016-210860
Henrotin Y, Addison S, Kraus V, Deberg M. Type II collagen markers in osteoarthritis: what do they indicate? Curr Opin Rheumatol. 2007;19(5):444-450. https://doi.org/10.1097/BOR.0b013e32829fb3b5
Birmingham JD, Vilim V, Kraus VB. Collagen biomarkers for arthritis applications. Biomark Insights. 2007;1:61-76.
Henrotin Y, Deberg M, Dubuc JE, Quettier E, Christgau S, Reginster JY. Type II collagen peptides for measuring cartilage degradation. Biorheology. 2004;41(3-4):543-547.
Deberg M, Labasse A, Christgau S, Cloos P, Bang Henriksen D, Chapelle JP, Zegels B, Reginster JY, Henrotin Y. New serum biochemical markers (Coll 2—1 and Coll 2—1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis. Osteoarthritis. Cartilage. 2005;13(3):258-265. https://doi.org/10.1016/j.joca.2004.12.002
Deberg MA, Labasse AH, Collette J, Seidel L, Reginster JY, Henrotin YE. One-year increase of Coll 2—1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression. Osteoarthritis. Cartilage. 2005;13(12):1059-1065. https://doi.org/10.1016/j.joca.2005.06.014
Möller I, Gharbi M, Serrano HM, Barbero MH, Milano JV, Henrotin Y. Effect of chondroitin sulfate on soluble biomarkers of osteoarthritis: a method to analyze and interpret the results from an open-label trial in unilateral knee osteoarthritis patients. BMC Musculoskeletal Disorders. 2016;17:416-421. https://doi.org/10.1186/s12891-016-1268-4
Martel-Pelletier J, Raynauld JP, Mineau, Abram F, Paiement P, Delorme P, Pelletier JP. Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed by magnetic resonance imaging: an exploratory study. Arthritis Res Ther. 2017;19:169. https://doi.org/10.1186/s13075-017-1377-y
Nakashima S, Matsuyama Y, Takahashi K, Satoh T, Koie H, Kanayama K, Tsuji T, Maruyama K, Imagama S, Sakai Y, Ishiguro N. Regeneration of intervertebral disc by the intradiscal application of cross-linked hyaluronate hydrogel and cross-linked chondroitin sulfate hydrogel in a rabbit model of intervertebral disc injury. Biomed Mater Eng. 2009;19(6):421-429. https://doi.org/10.3233/BME-2009-0608
Derby R, Eek B, Lee SH, Seo KS, Kim BJ. Comparison of intradiscal restorative injections and intradiscal electrothermal treatment (IDET) in the treatment of low back pain. Pain Physician. 2004;7(1):63-66.
Klein RG, Eek BC, O’Neill CW, Elin C, Mooney V, Derby RR. Biochemical injection treatment for discogenic low back pain: a pilot study. Spine J. 2003;3(3):220-226.
Leffler C, Philippi A, Leffler S, Mosure JC, Kim PD. Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study. Mil Med. 1999;164(2):85-91.
Chebykin AV. Opyt primeneniya hondroprotektora Artra u pacientov s bol’yu v spine. Nevrologiya, nejropsihiatriya, psihosomatika. 2012;3:67-72. (In Russ.)
Singh G, Alekseeva L, Alekseev V, Barinov A, et. al. Combination treatment with glucosamine-chondroitin sulfate reduces pain, disability and NSAID consumption in patients with chronic low back pain: final results from a large, community based, pilot, open prospective interventional study. Ann Rheum Dis. 2014;73(2):209. https://doi.org/10.1136/annrheumdis-2014-eular.1035
Shostak NA, Pravdyuk NG, Klimenko AA, Kondrashov AA, Egorova VA, Shvyreva NM. Degenerativnoe porazhenie pozvonochnika i bol’ v spine: podhody k terapii. Consilium Medicum. Nevrologiya, revmatologiya. 2013;15(2):37-42. (In Russ.)